Registry for patients with chronic airway diseases
Official title: Airway Registry for Chronic Airway Diseases
Run by Seoul National University Hospital · NCT02527486 · Data updated 2026-11-12
This study is gathering information from people with chronic airway diseases like COPD and asthma to better understand their conditions and find ways to improve their care.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 20 Years to 90 Years |
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | Seoul National University Hospital Academic / other |
| Locations | 3 sites (Seongnam-si, Gyeonggi-do and 2 other locations) |
| Status | Recruiting |
| Started | September 2011 |
| Main results expected | December 2021 |
| Study ends | December 2031 |
| Registry record updated | August 19, 2015 |
| Trial ID | NCT02527486 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study include individuals diagnosed with COPD, asthma, ACOS, bronchiectasis, or inactive tuberculosis of the lung.
✕Probably not a fit
Patients with acute respiratory conditions or those not meeting the specific inclusion criteria for chronic airway diseases may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter, prospective observational cohort study aims to recruit patients suffering from chronic airway diseases such as chronic obstructive pulmonary disease (COPD), asthma, asthma-COPD overlap syndrome (ACOS), bronchiectasis, and inactive tuberculosis of the lung. The study will collect data on these patients to better understand the characteristics and outcomes associated with these conditions. By observing a diverse patient population, the study seeks to identify patterns and potential areas for improved management of chronic airway diseases.
Why it matters
Potential benefit: If successful, this study could enhance the understanding and management of chronic airway diseases, leading to better patient outcomes.
How similar studies have gone: Other observational studies focusing on chronic respiratory diseases have shown success in identifying key factors influencing patient outcomes, suggesting that this approach is promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
COPD Inclusion Criteria: * Postbronchodilator FEV1/FVC \< 0.7 AND chronic respiratory symptom Exclusion Criteria: \- Asthma Inclusion Criteria: * Never smoker or \<5PY of smoking history AND Recurrent episodes of asthma symptoms (wheezing, dyspnea, chest tightness, cough) AND (either Positive BDR OR positive metacholine/mannitol/exercise provocation test) Exclusion Criteria: \- ACOS Inclusion Criteria: * COPD AND Asthma (regardless of smoking status) Exclusion Criteria: \-
Where it's running
-
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea Recruiting -
Seoul National University Hospital
Seoul, South Korea Recruiting -
Seoul Metropolitan Government-Seoul National University Boramae Medical Center
Seoul, South Korea Active not recruiting
Study contacts
- Study coordinator: Chang-Hoon Lee, M.D.
- Email: kauri670@gmail.com
- Phone: 82-2-2072-4743
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Chronic Respiratory Disease Participant Engagement
This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.
-
Understanding the impact of multimorbidity on chronic airway diseases
This study looks at how having multiple health issues affects people with chronic lung diseases like COPD, asthma, or bronchiectasis to help improve their care and treatment.
-
Breathlessness in respiratory diseases: who feels it and why
This study tests how physiology, psychology, function, and breathing patterns relate to breathlessness in people with respiratory conditions compared with healthy controls.
-
Breztri real-world safety and effectiveness in Korean patients with COPD or asthma
This post-marketing study tests Breztri in real-world Korean patients with COPD or asthma to see how safe it is and how well it works when used as usual care.
-
Effects of Wood Smoke on Lung Health in Adults
This study tests how different levels of woodsmoke exposure affect lung function and inflammatory responses in healthy adults.
-
Immune status and disease control in airway inflammatory diseases
This project will test whether specific blood immune cell patterns relate to disease control in adults with asthma, COPD, bronchiectasis, or obstructive sleep apnea by comparing them with healthy volunteers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.